160 related articles for article (PubMed ID: 28633753)
1. Tumor necrosis factor-induced alopecia: alternative pathology and therapy.
Udkoff J; Cohen PR
Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633753
[TBL] [Abstract][Full Text] [Related]
2. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
[TBL] [Abstract][Full Text] [Related]
3. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
[No Abstract] [Full Text] [Related]
4. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold.
Craddock LN; Cooley DM; Endo JO; Longley BJ; Caldera F
Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329519
[TBL] [Abstract][Full Text] [Related]
5. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
Zamperetti M; Zelger B; Höpfl R
Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
[TBL] [Abstract][Full Text] [Related]
6. Alopecia secondary to anti-tumor necrosis factor-alpha therapy.
Ribeiro LB; Rego JC; Estrada BD; Bastos PR; Piñeiro Maceira JM; Sodré CT
An Bras Dermatol; 2015; 90(2):232-5. PubMed ID: 25830994
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors.
Carrasquillo OY; Pabón-Cartagena G; Barrera-Llaurador J; Colón-Fontanez F; Martín-García RF
Cutis; 2021 Apr; 107(4):E48-E55. PubMed ID: 34096864
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab-induced scalp psoriasis with severe alopecia.
Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
[TBL] [Abstract][Full Text] [Related]
9. Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn's Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies.
Udkoff J; Cohen PR
Dermatol Ther (Heidelb); 2016 Dec; 6(4):689-695. PubMed ID: 27844446
[TBL] [Abstract][Full Text] [Related]
10. TNF-inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy.
Afanasiev OK; Zhang CZ; Ruhoy SM
J Cutan Pathol; 2017 Jun; 44(6):563-569. PubMed ID: 28332233
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab-related alopecia in a patient affected by psoriasis.
Melé-Ninot G; Expósito-Serrano V; Quintana Codina M; Iglesias Sancho M; Sánchez-Regaña M; Umbert Millet P; Salleras Redonnet M
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469696
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced psoriasiform alopecia associated with interleukin-17 inhibitor therapy.
Tan TL; Taglia L; Yazdan P
J Cutan Pathol; 2021 Jun; 48(6):771-774. PubMed ID: 33389767
[TBL] [Abstract][Full Text] [Related]
13. Psoriatic alopecia.
George SM; Taylor MR; Farrant PB
Clin Exp Dermatol; 2015 Oct; 40(7):717-21. PubMed ID: 26202646
[TBL] [Abstract][Full Text] [Related]
14. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R; Borges-Costa J
Acta Dermatovenerol Croat; 2019 Mar; 27(1):49-50. PubMed ID: 31032795
[TBL] [Abstract][Full Text] [Related]
18. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.
Afzali A; Wheat CL; Hu JK; Olerud JE; Lee SD
J Crohns Colitis; 2014 Jun; 8(6):480-8. PubMed ID: 24268978
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
20. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
